Zimmermann M - Search Results

1

Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia.

Hollink IH, van den Heuvel-Eibrink MM, Arentsen-Peters ST, Zimmermann M, Peeters JK, Valk PJ, Balgobind BV, Sonneveld E, Kaspers GJ, de Bont ES, Trka J, Baruchel A, Creutzig U, Pieters R, Reinhardt D, Zwaan CM. Hollink IH, et al. Among authors: zimmermann m. Haematologica. 2011 Mar;96(3):384-92. doi: 10.3324/haematol.2010.031336. Epub 2010 Dec 6. Haematologica. 2011. PMID: 21134981 Free PMC article.

2

[Acute myeloid leukemia in children with Down syndrome].

Creutzig U, Ritter J, Ludwig WD, Niemeyer C, Reinisch I, Stollmann-Gibbels B, Zimmermann M, Harbott J. Creutzig U, et al. Among authors: zimmermann m. Klin Padiatr. 1995 Jul-Aug;207(4):136-44. doi: 10.1055/s-2008-1046530. Klin Padiatr. 1995. PMID: 7564143 German.

3

Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87.

Creutzig U, Harbott J, Sperling C, Ritter J, Zimmermann M, Löffler H, Riehm H, Schellong G, Ludwig WD. Creutzig U, et al. Among authors: zimmermann m. Blood. 1995 Oct 15;86(8):3097-108. Blood. 1995. PMID: 7579404 Free article. Clinical Trial.

4

Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87.

Creutzig U, Ritter J, Zimmermann M, Schellong G. Creutzig U, et al. Among authors: zimmermann m. J Clin Oncol. 1993 Feb;11(2):279-86. doi: 10.1200/JCO.1993.11.2.279. J Clin Oncol. 1993. PMID: 8426205 Clinical Trial.

5

Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia.

Boos J, Hohenlöchter B, Schulze-Westhoff P, Schiller M, Zimmermann M, Creutzig U, Ritter J, Jurgens H. Boos J, et al. Among authors: zimmermann m. Med Pediatr Oncol. 1996 Jun;26(6):397-404. doi: 10.1002/(SICI)1096-911X(199606)26:6<397::AID-MPO5>3.0.CO;2-C. Med Pediatr Oncol. 1996. PMID: 8614376

6

Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group.

Creutzig U, Ritter J, Vormoor J, Ludwig WD, Niemeyer C, Reinisch I, Stollmann-Gibbels B, Zimmermann M, Harbott J. Creutzig U, et al. Among authors: zimmermann m. Leukemia. 1996 Nov;10(11):1677-86. Leukemia. 1996. PMID: 8892666

7

[Prognosis of children with chronic myeloid leukemia: a retrospective analysis of 75 patients].

Creutzig U, Ritter J, Zimmermann M, Klingebiel T. Creutzig U, et al. Among authors: zimmermann m. Klin Padiatr. 1996 Jul-Aug;208(4):236-41. doi: 10.1055/s-2008-1046479. Klin Padiatr. 1996. PMID: 8926689 German.

8

[Prognosis of children with acute myelocytic leukemia after first relapse].

Creutzig U, Ritter J, Boos J, Zimmermann M, Bender-Götze C, Stahnke K. Creutzig U, et al. Among authors: zimmermann m. Klin Padiatr. 1998 Jul-Aug;210(4):207-11. doi: 10.1055/s-2008-1043880. Klin Padiatr. 1998. PMID: 9743954 German.

9

Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemia.

Stahnke K, Boos J, Bender-Götze C, Ritter J, Zimmermann M, Creutzig U. Stahnke K, et al. Among authors: zimmermann m. Leukemia. 1998 Oct;12(10):1534-8. doi: 10.1038/sj.leu.2401141. Leukemia. 1998. PMID: 9766496

10

Definition of a standard-risk group in children with AML.

Creutzig U, Zimmermann M, Ritter J, Henze G, Graf N, Löffler H, Schellong G. Creutzig U, et al. Among authors: zimmermann m. Br J Haematol. 1999 Mar;104(3):630-9. doi: 10.1046/j.1365-2141.1999.01304.x. Br J Haematol. 1999. PMID: 10086807 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,471 results

Search Page